Speaker Profile
Ph.D., Director, Wake Forest School of Medicine
Biography
Dr. Olivier is Director of the Center for Precision Medicine, and Professor in the Department of Internal Medicine at Wake Forest School of Medicine. Prior to his current appointment, he was Chair of the Department of Genetics at the Texas Biomedical Research Institute in San Antonio, TX, and Professor of Physiology at the Biotechnology and Bioengineering Center at the Medical College of Wisconsin in Milwaukee, WI. Dr. Olivier’s research focused initially on the analysis of the genetic basis of human obesity and related co-morbidities. Research in his group has focused on the development of novel approaches to functionally characterize human sequence variants. For the the past two decades, his laboratory has integrated genomics with mass spectrometry (proteomics, metabolomics) to advance our understanding of how disease-associated sequence variants affect normal cell and organ function in a wide range of human diseases.
Clinical & Research Tools Showcase: Wake Forest School of Medicine
The presentation will outline the opportunities and advantages of longitudinal multi-omics analyses of molecular and cellular changes to identify molecular mechanisms, pathways, and networks that contribute to the development and progression of cardiometabolic diseases and other age-related health complications. We will demonstrate the feasibility of multi-omics profiling, and analytical approaches that can be used to extract relevant molecular information. These analyses can advance our understanding of the mechanisms contributing to diseases at the molecular level, opening the door to better diagnostic approaches to predict health trajectories, and improved targeted therapeutic approaches to improve health outcomes.
Integrated Multi-omics Analysis Approaches for Precision Medicine
The presentation will outline the opportunities and advantages of longitudinal multi-omics analyses of molecular and cellular changes to identify molecular mechanisms, pathways, and networks that contribute to the development and progression of cardiometabolic diseases and other age-related health complications. We will demonstrate the feasibility of multi-omics profiling, and analytical approaches that can be used to extract relevant molecular information. These analyses can advance our understanding of the mechanisms contributing to diseases at the molecular level, opening the door to better diagnostic approaches to predict health trajectories, and improved targeted therapeutic approaches to improve health outcomes.
